Search

This article is a case study in doing new things with old data. In 1953 Lord William Taylour directed the excavation of a monumental vaulted tholos tomb known as 'Tholos IV' at the site of ancient Pylos, Messenia, Greece. The excavation was conducted over two months, during which detailed notes were recorded in three notebooks now kept in the Archives of the American School of Classical Studies at Athens. The formal publication of Tholos IV, however, contains only a basic narrative of the excavation, offering neither precise detail on stratigraphy, object find spots, nor even a complete inventory of small finds. The present study goes back to the original notebooks kept by Taylour and combines the data contained in them with a new digital survey of Tholos IV to produce a comprehensive and accurate 3D GIS model for the excavation. Furthermore, the GIS has been produced in such a way that its dataset is compatible with new excavation data currently generated in the ongoing Palace of Nestor Excavations (PONEX) project, bringing together two excavation campaigns conducted under very different circumstances, methodologies, and recording protocols. Discussion follows on how the production of this GIS deepens our understanding not just of the legacy excavation, but also of the site and its wider landscape.

This case report describes an elderly patient with radioiodine-resistant differentiated thyroid cancer and additional multiple metastases living in a rural setting, remote from the specialist oncology service. This case is of interest because effective systemic therapies for treatment-resistant cancers, such as lenvatinib, are now available but can potentially cause significant toxicities that require extensive medical management. Here, we discuss how patient care was provided collaboratively by the local community teams integrated with remote specialist oncology services. A 77-year-old patient presented with symptoms of cauda equina secondary to a large metastatic sacral deposit. The deposit was biopsied, and histology revealed a diagnosis of differentiated follicular thyroid cancer that was treated with external beam radiotherapy and thyroidectomy, followed by radioiodine. However, the disease was found to be resistant to radioiodine therapy, and the patient subsequently developed back pain due to new bone metastases. After further palliative external beam radiotherapy, the patient was started on systemic treatment with lenvatinib. Treatment has continued for more than 2.5 years with a slow but steady improvement in symptoms and quality of life. Monitoring and assessment of lenvatinib therapy and management of associated toxicities was coordinated remotely from a specialist cancer center over 200 miles away, using the skills of the local medical and nursing teams. This case report demonstrates how a cooperative effort using local teams and video-conferencing links to a specialist cancer center can be applied to safely treat a patient with a medication that may result in significant potential toxicities that require attentive and dynamic management.